Kim Theilgaard-Mønch

CV

Education

1984                  Graduation, Kurfürst-Friedrich Gymnasium, Heidelberg, DE.

1992                  MD degree, Univ. Heidelberg, Munich, Hannover, DE

1994                  MD degree USA, ECFMG certificate.

2007                  DMSc, Rigshospitalet, Univ. of CPH, DK.

2017                  Board certifiedspecialist Internal Medicine and Haematology, DK+SE.

Career

Since 2018

Combined clinical and research position: Senior Consulatant, Dept. pf Haematology, Rigshospitalet,  50% Group Leader and Associate Prof.. Finsen Laboratory, Rigshospitalet, Biotech Research and Innovation Centre, DanStem, Univ. of CPH, DK (Novo Nordisk clinical research scholarship 2013-2017).

2008-2017

Combined clinical and research position: Since 2013 50% Group Leader and Associate Prof.. Finsen Laboratory, Rigshospitalet & Biotech Research and Innovation Centre, Univ. of CPH, DK (Novo Nordisk clinical research scholarship 2013-2017), 50% Clinician (1.RL), Dept. of Hematology, Univ. of Lund, SE.

2005-2007      

Post.doc., Laboratory for Gene Therapy Research, Rigshospitalet, University of Copenhagen, Denmark.

1998-2004      

DMSc reserach fellow, The Granulocyte Research Laboratory, Dept. of Haematology, Rigshospitalet, University of Copenhagen.

1992 -1998     
Clinician, Dept.  of Haematology-Oncology (24 month), University of Heidelberg, DE. Dept. of Clinical Immunology (21 month) and Dept. of Haematology (12 month), Rigshospitalet, University of CPH, DK.

Primary fields of research

Acute Myeloid Leukemia

Hematopoietic stem cells

Current research

Identification and therapeutic targeting of "oncogenic" signaling and DNA damage response patways in preclinical models of human AML.

Novel antibody-drug conjugate therapy for AML.

Maping of cloncal evolution in AML patients.

Identification of novel human hematopoietic stem cell markers for clinical application  

Fields of interest

Leukemia - therapy/genetics 
Gene regulation
Normal and malignant hematopoietic/myeloid development